Table 3.
Association between metabolic risk factors and FBG levels at baseline and follow up
| Variables | FBG (baseline) | X2, df (p value) | p value | FBG (follow up) | X2, df (p value) | p value | ||
|---|---|---|---|---|---|---|---|---|
| High (n = 147) | Normal (n = 94) | aOR (95% CI) | High (n = 94) | Normal (n = 66) | aOR (95% CI) | |||
| Gender | 1.38, 1 (0.239) | 3.55, 1 (0.06) | ||||||
| Male | 56 (38.1) | 43 (45.7) | 1.0# | 33 (35.1) | 33 (50.0) | 1.0# | ||
| Female | 91 (61.9) | 51 (54.3) | 1.37 (0.81–2.32) | 0.283 | 61 (64.9) | 33 (50.0) | 1.85 (0.97–3.51) | 0.073 |
| BMI | 2.18, 3 (0.537) | 1.77, 3 (0.622) | ||||||
| Underweight | 6 (4.1) | 3 (3.2) | 1.05 (0.25–4.47) | 1.000 | 2 (2.1) | 1 (1.5) | 1.40 (0.12–16.21) | 1.000 |
| Normal | 70 (47.9) | 37 (39.4) | 1.0# | 40 (42.6) | 28 (43.1) | 1.0# | ||
| Overweight | 46 (31.5) | 34 (36.2) | 0.72 (0.39–1.29) | 0.289 | 29 (30.9) | 23 (35.4) | 0.88 (0.43–1.83) | 0.852 |
| Obese | 24 (16.4) | 20 (21.3) | 0.63 (0.31–1.30) | 0.268 | 23 (24.5) | 14 (21.5) | 1.15 (0.51–2.62) | 0.836 |
| SBP | 0.87, 1 (0.351) | 1.13, 1(0.288) | ||||||
| Normal | 77 (52.4) | 55 (58.5) | 1.0# | 49 (52.1) | 40 (60.6) | 1.0# | ||
| High | 70 (47.6) | 39 (41.5) | 1.28 (0.76–2.16) | 0.357 | 45 (47.9) | 26 (39.4) | 1.41 (0.75–2.68) | 0.333 |
| DBP | 0.02, 1 (0.901) | 2.34, 1(0.126) | ||||||
| Normal | 108 (73.5) | 69 (74.2) | 1.0# | 67 (73.1) | 54 (81.8) | 1.0# | ||
| High | 39 (26.5) | 24 (25.8) | 1.04 (0.57–1.88) | 1.000 | 27 (28.7) | 12 (18.2) | 1.81 (0.84–3.91) | 0.139 |
| TC | 0.22, 1 (0.642) | 0.09, 1 (0.764) | ||||||
| Good | 92 (63.0) | 62 (66.0) | 1.0# | 62 (66.0) | 43 (68.3) | 1.0# | ||
| High | 54 (37.0) | 32 (34.0) | 1.14 (0.67–1.96) | 0.681 | 32 (34.0) | 20 (31.7) | 1.11 (0.56–2.19) | 0.863 |
| TG | 0.23, 1(0.630) | 0.52,1 (0.472) | ||||||
| Good | 120 (81.6) | 79 (84.0) | 1.0# | 85 (90.4) | 59 (93.7) | 1.0# | ||
| High | 27 (18.4) | 15 (16.0) | 1.19 (0.59–2.37) | 0.729 | 9 (9.6) | 4 (6.3) | 1.56 (0.46–5.31) | 0.565 |
| HDL-c | 0.01, 1(0.928) | 0.83,1 (0.363) | ||||||
| Good | 115 (78.2) | 74 (78.7) | 1.0# | 25 (26.6) | 21 (33.3) | 1.0# | ||
| Low | 32 (21.8) | 20 (21.30) | 1.03(0.55–1.93) | 1.000 | 69 (73.4) | 42 (66.7) | 1.38 (0.69–2.77) | 0.377 |
| Non-HDL | 0.05, 1 (0.827) | 0.24,1 (0.621) | ||||||
| Normal | 72 (49.3) | 45 (47.5) | 1.0# | 41 (43.6) | 30 (47.6) | 1.0# | ||
| High | 74 (50.7) | 49 (52.1) | 0.94 (0.56–1.59) | 0.895 | 53 (56.4) | 33 (52.4) | 1.18 (0.62–2.23) | 0.628 |
| LDL-c | 0.88, 1 (0.349) | 0.84,1 (0.358) | ||||||
| Good | 68 (46.6) | 38 (40.4) | 1.0# | 32 (34.0) | 26 (41.3) | 1.0# | ||
| High | 78 (53.4) | 56 (59.6) | 0.78 (0.46–1.32) | 0.355 | 62 (66.0) | 37 (58.7) | 1.36 (0.71–2.63) | 0.401 |
Logistic regression model, adjusted for age and medication. 1.0#: reference point for odds ratio
X 2, df Chi square value, degrees of freedom, aOR adjusted odds ratio, CI confidence interval